Unknown

Dataset Information

0

Correction: AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models.

ABSTRACT:

SUBMITTER: Vasireddy V 

PROVIDER: S-EPMC4474960 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models.
| S-EPMC3646845 | biostudies-literature
Unknown Gene therapy for choroideremia using an adeno-associated viral (AAV) vector.
| S-EPMC4355255 | biostudies-literature
Unknown Lentivirus- or AAV-mediated gene therapy interventions in ischemic stroke: A systematic review of preclinical <i>in vivo</i> studies.
| S-EPMC8795232 | biostudies-literature
Unknown Choroideremia Gene Therapy.
| S-EPMC8478312 | biostudies-literature
Unknown AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models.
| S-EPMC5333052 | biostudies-other
Unknown AAV-Mediated Gene Supplementation Therapy in Achromatopsia Type 2: Preclinical Data on Therapeutic Time Window and Long-Term Effects.
| S-EPMC5442229 | biostudies-literature
Unknown Emerging Issues in AAV-Mediated In Vivo Gene Therapy.
| S-EPMC5758940 | biostudies-literature
Unknown Advancements in AAV-mediated Gene Therapy for Pompe Disease.
| S-EPMC7029369 | biostudies-literature
Unknown A comparison of AAV-vector production methods for gene therapy and preclinical assessment.
| S-EPMC7726153 | biostudies-literature
Unknown AAV-mediated gene therapy for metabolic diseases: dosage and reapplication studies in the molybdenum cofactor deficiency model.
| S-EPMC2702341 | biostudies-literature